[1] Zgavc T, Ceulemans A G, Sarre S, et al. Experimental and clinical use of therapeutic hypothermia for ischemic stroke: opportunities and limitations [J]. Stroke Res Treat, 2011, 2011: 689290.[2] Turner R J, Vink R. Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats [J]. Neuroscience, 2012, 220: 1-10.[3] Copin J C, Bengualid D J, Da Silva R F, et al. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse [J]. Eur J Neurosci, 2011, 34(7): 1085-1092.[4] Feiler S, Plesnila N, Thal S C, et al. Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage [J]. Cerebrovasc Dis, 2011, 32(3): 289-295.[5] Longa E Z, Weinstein P R, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats [J]. Stroke, 1989, 20(1): 84-91.[6] Belayev L, Alonso O F, Busto R, et al. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model [J]. Stroke, 1996, 27(9): 1616-1622.[7] Klassman L. Therapeutic hypothermia in acute stroke [J]. J Neurosci Nurs, 2011, 43(2): 94-103.[8] Banerjee S, Bhat M A. Neuron-glial interactions in blood-brain barrier formation [J]. Annu Rev Neurosci, 2007, 30: 235-258.[9] Baeten K M, Akassoglou K. Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke [J]. Dev Neurobiol, 2011, 71(11): 1018-1039.[10] Rosenberg G A, Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia [J]. Neurosurg Focus, 2007, 22(5): e4.[11] Takata F, Dohgu S, Matsumoto J, et al. Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-α, releasing matrix metalloproteinase-9 and migrating in vitro [J]. J Neuroinflammation, 2011, 8: 106.[12] Dafnis I, Tzinia A K, Tsilibary E C, et al. An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines [J]. Neuroscience, 2012, 210: 21-32.[13] Zhao H, Li C S, Gong P, et al. Molecular mechanisms of therapeutic hypothermia on neurological function in a swine model of cardiopulmonary resuscitation [J]. Resuscitation, 2012, 83(7): 913-920.[14] Cui J, Chen S, Zhang C, et al. Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia [J]. Mol Neurodegener, 2012, 7(1):21.[15] Khan M M, Gandhi C, Chauhan N, et al. Alternatively-spliced extra domain A of fibronectin promotes acute inflammation and brain injury after cerebral ischemia in mice [J]. Stroke, 2012, 43(5): 1376-1382. |